RxSight (RXST) Asset Utilization Ratio (2021 - 2026)
RxSight (RXST) posted Asset Utilization Ratio of 0.41 for Q1 2026, down 4.51% on a QoQ basis from 0.43 in Q4 2025, and down 11.84% year-over-year from 0.47 in Q1 2025.
RxSight (RXST) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
RxSight's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.41 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 11.84% year-over-year to 0.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.41 (down 11.84% YoY) and the FY2025 annual result came in at 0.43, down 23.6% from the prior year.
- Asset Utilization Ratio was 0.41 for Q1 2026 at RxSight, down from 0.43 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2024 and bottomed at 0.15 in Q1 2022.
- A 5-year average of 0.39 and a median of 0.42 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 706.48% — and 2025, when it retreated 15.06%.
- RxSight's Asset Utilization Ratio stood at 0.32 in 2022, then soared by 52.58% to 0.49 in 2023, then retreated by 9.0% to 0.44 in 2024, then fell by 2.55% to 0.43 in 2025, then retreated by 4.51% to 0.41 in 2026.
- Business Quant data shows RXST's Asset Utilization Ratio at 0.41 in Q1 2026, 0.43 in Q4 2025, and 0.46 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.46 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.47 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.42 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | 0.32 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | 0.03 |